Balchem Co. (NASDAQ:BCPC) Shares Sold by SG Americas Securities LLC

SG Americas Securities LLC reduced its holdings in shares of Balchem Co. (NASDAQ:BCPC – Get Rating) by 72.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,638 shares of the basic materials company’s stock after selling 14,849 shares during the period. SG Americas Securities LLC’s holdings in Balchem were worth $771,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently added to or reduced their stakes in the business. Nisa Investment Advisors LLC acquired a new position in Balchem during the 1st quarter valued at about $784,000. Summit Global Investments increased its position in Balchem by 7.2% during the 1st quarter. Summit Global Investments now owns 10,969 shares of the basic materials company’s stock valued at $1,499,000 after buying an additional 733 shares in the last quarter. Carderock Capital Management Inc. increased its position in Balchem by 11.8% during the 1st quarter. Carderock Capital Management Inc. now owns 19,428 shares of the basic materials company’s stock valued at $2,656,000 after buying an additional 2,046 shares in the last quarter. Hardy Reed LLC acquired a new position in Balchem during the 1st quarter valued at about $119,000. Finally, Comerica Bank increased its position in Balchem by 2.0% during the 1st quarter. Comerica Bank now owns 102,156 shares of the basic materials company’s stock valued at $13,645,000 after buying an additional 1,978 shares in the last quarter. 89.60% of the stock is owned by institutional investors and hedge funds.

Balchem Stock Down 5.8 %

Shares of BCPC opened at $127.86 on Tuesday. Balchem Co. has a 52 week low of $110.15 and a 52 week high of $174.29. The company has a quick ratio of 1.64, a current ratio of 2.62 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $4.11 billion, a price-to-earnings ratio of 38.28 and a beta of 0.59. The stock’s 50-day moving average price is $126.24 and its 200-day moving average price is $131.83.

Balchem (NASDAQ:BCPC – Get Rating) last issued its earnings results on Friday, April 29th. The basic materials company reported $0.89 EPS for the quarter, topping analysts’ consensus estimates of $0.73 by $0.16. Balchem had a return on equity of 12.84% and a net margin of 12.40%. The firm had revenue of $228.87 million for the quarter, compared to the consensus estimate of $211.00 million. During the same quarter in the prior year, the business earned $0.87 earnings per share. On average, sell-side analysts predict that Balchem Co. will post 3.46 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on BCPC shares. StockNews.com lowered Balchem from a “buy” rating to a “hold” rating in a report on Monday. HC Wainwright cut their price objective on Balchem from $155.00 to $152.00 and set a “buy” rating on the stock in a report on Monday, May 2nd.

Balchem Profile

(Get Rating)

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.

Recommended Stories

• Get a free copy of the StockNews.com research report on Balchem (BCPC)
• MarketBeat Podcast: Find Investing Opportunities For The Rest of 2022
• Deep Value High Yield Newell Brands Is Ready To Bottom 
• The Colgate-Palmolive Growth Outlook Brightens 
• These Stocks Outperformed Last Time There Was A Recession
• Does Rivian’s Stock Still Have A Future?

Want More Great Investing Ideas?